{"id":813200,"date":"2025-02-13T17:04:05","date_gmt":"2025-02-13T22:04:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"modified":"2025-02-13T17:04:05","modified_gmt":"2025-02-13T22:04:05","slug":"profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","title":{"rendered":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">TORONTO, Feb.  13, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_CBu7zskpus8g2C1ERB_Zc2pCdzFCADvWHI8XoLAzIpAsYKXPBieF0Pok-lha5ISc5Dgi_2QrSkefLJ4JGz6ugtg5ARXoe7uwedxzEgB4kI=\" rel=\"nofollow\" target=\"_blank\"><u>Profound Medical Corp.<\/u><\/a> (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025.<\/p>\n<p align=\"justify\">Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.<\/p>\n<p align=\"justify\">\n        <strong>Fourth Quarter and Full Year 2024 Results Conference Call Details:<\/strong>\n      <\/p>\n<p align=\"justify\">Date: Thursday, March 6, 2025<\/p>\n<p align=\"justify\">Time: 4:30 p.m. ET<\/p>\n<p align=\"justify\">Live Call Registration: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d4kCoqo0FU_fd34v6QAsma5DwSGUCTIL7VAi09aGtcloc0tAeZrVfDkxtTMYBm7jMfyQy_AwmXUujU1xP0PJ6Pe-G6DQBBNmiM3pljOyHsI68uEMMwoV9nNwqdSWWKzcdg8Hh3kFnpfJP3-v_K64PGWPbOyZrrU1RjXt7AkFnskmHPSXcQ8SW5RpGg-xduf4bqiVC5ZQwRNxF7cHvMtZy_FKfBVjIP5oYqyOQer_8rc=\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/register.vevent.com\/register\/BI4fc1c4c3061645ca9f513f8f017abfbb<\/u><\/a><\/p>\n<p align=\"justify\">The call will also be broadcast live and archived on the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2NVOqDhl5kuMuA7S1hPesn0QKLs0szKOqbbLyLV3cyjFLqFpnhRo5qFUBCFuzOnKI5ZBxkXz1AiMuEoe-neVigc0X02NjdAoXcdUSdOOeEg=\" rel=\"nofollow\" target=\"_blank\"><u>www.profoundmedical.com<\/u><\/a> under \u201cWebcasts\u201d in the Investors section.<\/p>\n<p align=\"justify\">\n        <strong>About Profound Medical Corp.<\/strong>\n      <\/p>\n<p align=\"justify\">Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.<\/p>\n<p align=\"justify\">Profound is commercializing TULSA-PRO<sup>\u00ae<\/sup>, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO<sup>\u00ae<\/sup> system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (\u201cBPH\u201d); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. TULSA employs real-time MR guidance for precision to preserve patients\u2019 urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57\u00b0C. TULSA is an incision- and radiation-free \u201cone-and-done\u201d procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with TULSA. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report quick recovery to their normal routine. TULSA-PRO<sup>\u00ae<\/sup> is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (\u201cFDA\u201d).<\/p>\n<p align=\"justify\">Profound is also commercializing Sonalleve<sup>\u00ae<\/sup>, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve<sup>\u00ae<\/sup> has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve<sup>\u00ae<\/sup> where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.<\/p>\n<p align=\"justify\">\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Stephen Kilmer<br \/>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zrcs2_V8gHOpa5MPs46HE7LQOGIfgv_ve4l08EX0ANraFVSn7Igi3BN2oYkrModOhoPOxvBcj8_P70xOfuXcPIXZW-yfYGFDkMftKJHXmdFqEHIcfJxDlrbQJ1L3z_vm\" rel=\"nofollow\" target=\"_blank\"><u>skilmer@profoundmedical.com<\/u><\/a><br \/>T: 647.872.4849<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGY4NTkxMzAtMTE1My00YTI2LTkwMzUtNmVjNGM4Nzc4NWRmLTEwMzAxMTk=\/tiny\/Profound-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference Call Details: Date: Thursday, March 6, 2025 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI4fc1c4c3061645ca9f513f8f017abfbb The call will also be broadcast live and archived on the Company&#8217;s website at www.profoundmedical.com under \u201cWebcasts\u201d in the Investors section. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-813200","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference Call Details: Date: Thursday, March 6, 2025 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI4fc1c4c3061645ca9f513f8f017abfbb The call will also be broadcast live and archived on the Company&#8217;s website at www.profoundmedical.com under \u201cWebcasts\u201d in the Investors section. &hellip; Continue reading &quot;Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T22:04:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\",\"datePublished\":\"2025-02-13T22:04:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/\"},\"wordCount\":467,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/\",\"name\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\",\"datePublished\":\"2025-02-13T22:04:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","og_locale":"en_US","og_type":"article","og_title":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk","og_description":"TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference Call Details: Date: Thursday, March 6, 2025 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI4fc1c4c3061645ca9f513f8f017abfbb The call will also be broadcast live and archived on the Company&#8217;s website at www.profoundmedical.com under \u201cWebcasts\u201d in the Investors section. &hellip; Continue reading \"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-13T22:04:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow","datePublished":"2025-02-13T22:04:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"wordCount":467,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","name":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=","datePublished":"2025-02-13T22:04:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODQyMyM2NzUxMDc3IzIwMTg1NDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=813200"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813200\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=813200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=813200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=813200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}